|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01558 HEC CJ PHARM
Nominal 
9.340 -0.200 (-2.096%) Non-current Assets
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 | 0 | 0 |
| Property, plant, equip. & others | 3,398,369 | 7.217% | 3,169,613 | 2,858,808 | 2,489,661 | 1,790,722 |
| Land & other Lease Assets | 342,055 | -2.033% | 349,152 | 357,747 | 346,045 | 234,785 |
| Intangible Assets | 2,565,626 | -12.156% | 2,920,646 | 3,347,886 | 2,785,487 | 904,191 |
| Interests in Asso. & JCEs | 12,571 | -- | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 372,652 | -14.602% | 436,369 | 1,919,764 | 675,964 | 1,651,932 |
| 6,691,273 | -2.683% | 6,875,780 | 8,484,205 | 6,297,157 | 4,581,630 | |
Current Assets
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Inventories | 409,050 | 29.846% | 315,027 | 279,696 | 378,268 | 192,321 | |
| Trade Receivables | 2,072,611 | 106.062% | 1,005,817 | 479,041 | 460,509 | 2,196,381 | |
| Cash & Bank Balances | 1,674,413 | 81.303% | 923,543 | 1,131,121 | 2,044,967 | 2,779,138 | |
| Other Current Assets | 1,896,982 | 314.810% | 457,313 | 167,518 | 380,366 | 162,869 | |
| Assets Held for Sale | 0 | -- | 2,312,320 | 0 | 0 | 0 | |
| 6,053,056 | 20.723% | 5,014,020 | 2,057,376 | 3,264,110 | 5,330,709 | ||
Current Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |||
| Trade Payables | 200,088 | 19.536% | 167,387 | 115,322 | 239,551 | 184,694 | ||
| S-T Debt & Leases | 2,319,877 | -25.890% | 3,130,306 | 48,477 | 2,820,804 | 132,660 | ||
| Other Current Liabilities | 1,812,255 | 10.296% | 1,643,088 | 1,074,265 | 1,100,858 | 1,994,295 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | ||
| 4,332,220 | -12.317% | 4,940,781 | 1,238,064 | 4,161,213 | 2,311,649 | |||
| Net Current Assets | 1,720,836 | 2249.617% | 73,239 | 819,312 | (897,103) | 3,019,060 | ||
| Total Assets Less Current Liabilities | 8,412,109 | 21.055% | 6,949,019 | 9,303,517 | 5,400,054 | 7,600,690 | ||
Non-current Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||||
| L-T Debt & Leases | 289,451 | -58.143% | 691,529 | 3,145,025 | 189,853 | 2,902,600 | |||
| Other Non-current Liabilities | 187,145 | -0.183% | 187,489 | 137,730 | 106,542 | 74,935 | |||
| 476,596 | -45.781% | 879,018 | 3,282,755 | 296,395 | 2,977,535 | ||||
Capital and Reserves
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |||||
| Share Capital | 879,968 | 0.000% | 879,968 | 879,968 | 879,968 | 448,820 | ||||
| Reserves | 7,055,545 | 40.972% | 5,004,916 | 4,928,313 | 4,011,135 | 3,959,735 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | 7,935,513 | 34.846% | 5,884,884 | 5,808,281 | 4,891,103 | 4,408,555 | ||||
| Non-controlling Interests | 0 | -- | 185,117 | 212,481 | 212,556 | 214,600 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| 7,935,513 | 30.733% | 6,070,001 | 6,020,762 | 5,103,659 | 4,623,155 | |||||
Commitments and Contingent Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Commitments | 1,995,174 | 6.341% | 1,876,199 | 2,121,064 | 2,201,644 | 1,432,891 |
| Contingent Liabilities | 0 | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 22/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 684,731 |
| %Change | -33.489% |
| EPS / (LPS) | RMB 0.780 |
| NBV Per Share (¥) | RMB 9.847 |